Management ChangeMay 5, 2026, 12:46 PM
Curaleaf Appoints Torsten Greif to Board of Directors
AI Summary
Curaleaf Holdings, Inc. announced the appointment of Torsten Greif to its Board of Directors. Mr. Greif is a respected entrepreneur and a founder of Four 20 Pharma GmbH, Curaleaf's key German brand, bringing extensive expertise in cannabis cultivation and regulatory strategy. His appointment is expected to be a significant asset as Curaleaf continues to scale its European operations and integrate its European footprint.
Key Highlights
- Curaleaf appointed Torsten Greif to its Board of Directors.
- Mr. Greif is a founder of Four 20 Pharma GmbH, Curaleaf's flagship German brand.
- He brings deep expertise in cannabis cultivation, regulatory strategy, and brand development.
- His leadership was instrumental in positioning Four 20 Pharma as a leading premium cannabis provider in Germany.
- The appointment reinforces Curaleaf's commitment to strategic leadership and European expansion.
Price Impact
More from CURLF